Christian Schmidt, Associate Director at Phastar, explores how real-time data (RTD) analytics is helping sponsors overcome some of the most persistent challenges in clinical trial management. In this latest article for PharmaExec, he examines why traditional data review processes are struggling to keep pace with the growing volume, complexity, and fragmentation of clinical trial data, and explains how advanced analytics platforms can deliver the timely, actionable insights needed to support better decision-making and trial oversight.
The article highlights key challenges including data overload, recruitment forecasting, site monitoring, and maintaining data quality across multiple sources. Christian discusses how technologies such as predictive modelling, AI-powered analytics, risk-based quality management (RBQM), centralized dashboards, and interactive data visualizations can help sponsors identify risks earlier, optimize resources, and improve patient safety. By moving away from fragmented, manual processes and adopting a unified data strategy, organizations can unlock the full potential of real-time data and position themselves for the future of clinical development.